The story of Rosie, an eight-year-old Staffy cross Shar Pei from Sydney whose owner used AI and genomic sequencing to design a personalised mRNA cancer vaccine, captured global attention in early 2026. It is a genuinely remarkable case. It is also widely misread, and...

A research team at the Hong Kong University of Science and Technology has done something that was not supposed to be possible: they have flipped the fundamental logic of CRISPR gene editing. Published in Nature Biotechnology this month, the work by Professor Hsing...

The 2026–27 Federal Budget provides several positive signals for genomics and precision medicine in Australia, particularly across precision oncology, clinical trials, medicines access, digital health and innovation policy. For InGeNA members, the Budget reflects...